ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,998,456 | -17.4% | 666,152 | +3.0% | 0.00% | – |
| Q2 2023 | $2,418,819 | +2.4% | 646,743 | -8.3% | 0.00% | – |
| Q1 2023 | $2,361,897 | -30.9% | 705,044 | -0.8% | 0.00% | -100.0% |
| Q4 2022 | $3,419,612 | -17.1% | 710,938 | -2.0% | 0.00% | 0.0% |
| Q3 2022 | $4,127,000 | -16.1% | 725,226 | +4.6% | 0.00% | 0.0% |
| Q2 2022 | $4,921,000 | +21.7% | 693,126 | +23.8% | 0.00% | 0.0% |
| Q1 2022 | $4,043,000 | -21.4% | 560,020 | -2.7% | 0.00% | 0.0% |
| Q4 2021 | $5,143,000 | -75.2% | 575,268 | -2.7% | 0.00% | -75.0% |
| Q3 2021 | $20,733,000 | +85.5% | 591,361 | +13.6% | 0.00% | +100.0% |
| Q2 2021 | $11,179,000 | +8.3% | 520,422 | +211.3% | 0.00% | 0.0% |
| Q1 2021 | $10,321,000 | +39.6% | 167,160 | -5.5% | 0.00% | +100.0% |
| Q4 2020 | $7,391,000 | – | 176,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |